Literature DB >> 19878357

Perforin-expressing cytotoxic cells contribute to chronic cardiomyopathy in Trypanosoma cruzi infection.

Jaline Coutinho Silverio1, Luzia Maria de-Oliveira-Pinto, Andréa Alice da Silva, Gabriel Melo de Oliveira, Joseli Lannes-Vieira.   

Abstract

Understanding the dual participation of the immune response in controlling the invader and at the same time causing tissue damage might contribute to the design of effective new vaccines and therapies for Chagas disease. Perforin, a cytolytic protein product of killer cells, is involved in resistance to acute Trypanosoma cruzi infection. However, the contribution of perforin in parasite control and chronic chagasic cardiomyopathy is unclear. Perforin-positive cells were detected in the heart tissue during the acute and chronic phases of infection of C57BL/6 mice inoculated with low dose (10(2) parasites) of the Colombian T. cruzi strain. This protocol led to acute phase survival in both wild-type and perforin null (pfp(-/-)) mice lineages. During the chronic infection, parasitism and inducible nitric oxide synthase (iNOS) as well as interleukin (IL)-4+ and, mainly, interferon (IFN)-gamma+ cells were more elevated in the heart tissue of pfp(-/-) mice. Higher levels of circulating NO and anti-parasite immunoglobulin (Ig)G2c and IgG3, paralleled by a prominent frequency of IFN-gamma+ and IL-10+ splenocytes, were present in pfp(-/-)-infected mice. Therefore, although the perforin-dependent pathway plays a role, it is not crucial for anti-T. cruzi immunity and acute phase survival of mice infected with a low inoculum. Further, perforin deficiency resulted in lower activity of creatine kinase-muscle brain isoform (CK-MB) isoenzyme in serum and a more restricted connexin 43 loss, both of which are markers of the cardiomyocyte lesion. Moreover, perforin deficiency hampered the development of severe electrocardiographic abnormalities. Hence, our results corroborate that perforin-bearing cytotoxic cells might contribute to cardiomyocyte lesion and heart dysfunction during chronic T. cruzi infection, shedding light on immunopathogenesis of chronic chagasic cardiomyopathy.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19878357      PMCID: PMC2812730          DOI: 10.1111/j.1365-2613.2009.00670.x

Source DB:  PubMed          Journal:  Int J Exp Pathol        ISSN: 0959-9673            Impact factor:   1.925


  48 in total

1.  Trypanosoma cruzi: roles for perforin-dependent and perforin-independent immune mechanisms in acute resistance.

Authors:  S P Nickell; D Sharma
Journal:  Exp Parasitol       Date:  2000-04       Impact factor: 2.011

2.  CHRONIC AND PROGRESSIVE MYOCARDITIS AND MYOSITIS IN C3H MICE INFECTED WITH TRYPANOSOMA CRUZI.

Authors:  E E FEDERICI; W H ABELMANN; F A NEVA
Journal:  Am J Trop Med Hyg       Date:  1964-03       Impact factor: 2.345

Review 3.  Where do we stand on the autoimmunity hypothesis of Chagas disease?

Authors:  Felipe Kierszenbaum
Journal:  Trends Parasitol       Date:  2005-08-25

Review 4.  Delivering the kiss of death: progress on understanding how perforin works.

Authors:  Matthew E Pipkin; Judy Lieberman
Journal:  Curr Opin Immunol       Date:  2007-04-12       Impact factor: 7.486

5.  Functional IL-10 gene polymorphism is associated with Chagas disease cardiomyopathy.

Authors:  Germano C Costa; Manoel Otávio da Costa Rocha; Paula Rocha Moreira; Cristiane Alves Silva Menezes; Micena R Silva; Kenneth J Gollob; Walderez O Dutra
Journal:  J Infect Dis       Date:  2009-02-01       Impact factor: 5.226

Review 6.  Alterations in cardiac connexin expression in cardiomyopathies.

Authors:  Nicholas J Severs; Emmanuel Dupont; Neil Thomas; Riyaz Kaba; Stephen Rothery; Revti Jain; Katherine Sharpey; Christopher H Fry
Journal:  Adv Cardiol       Date:  2006

7.  Expression of cardiac cytokines and inducible form of nitric oxide synthase (NOS2) in Trypanosoma cruzi-infected mice.

Authors:  H Huang; J Chan; M Wittner; L A Jelicks; S A Morris; S M Factor; L M Weiss; V L Braunstein; C J Bacchi; N Yarlett; M Chandra; J Shirani; H B Tanowitz
Journal:  J Mol Cell Cardiol       Date:  1999-01       Impact factor: 5.000

Review 8.  Pathogenesis of chronic Chagas heart disease.

Authors:  Jose Antonio Marin-Neto; Edécio Cunha-Neto; Benedito C Maciel; Marcus V Simões
Journal:  Circulation       Date:  2007-03-06       Impact factor: 29.690

9.  Treatment of chronically Trypanosoma cruzi-infected mice with a CCR1/CCR5 antagonist (Met-RANTES) results in amelioration of cardiac tissue damage.

Authors:  Gabriela A Medeiros; Jaline C Silvério; Ana Paula M P Marino; Ester Roffê; Valeska Vieira; Karina Kroll-Palhares; Cristiano E Carvalho; Andréa Alice Silva; Mauro M Teixeira; Joseli Lannes-Vieira
Journal:  Microbes Infect       Date:  2008-12-07       Impact factor: 2.700

10.  Modulation of CD4(+) T cell-dependent specific cytotoxic CD8(+) T cells differentiation and proliferation by the timing of increase in the pathogen load.

Authors:  Fanny Tzelepis; Pedro M Persechini; Mauricio M Rodrigues
Journal:  PLoS One       Date:  2007-04-25       Impact factor: 3.240

View more
  12 in total

1.  A Parasite Biomarker Set for Evaluating Benznidazole Treatment Efficacy in Patients with Chronic Asymptomatic Trypanosoma cruzi Infection.

Authors:  Ana Fernández-Villegas; Elena Pérez-Antón; Inmaculada Gómez; Adriana Egui; M Carmen Thomas; Bartolomé Carrilero; Ángel Del Pozo; Maialen Ceballos; Eduardo Andrés-León; Miguel Ángel López-Ruz; Eusebio Gainza; Enrique Oquiñena; Manuel Segovia; Manuel Carlos López
Journal:  Antimicrob Agents Chemother       Date:  2019-09-23       Impact factor: 5.191

2.  Increased CD4+/CD8+ double-positive T cells in chronic Chagasic patients.

Authors:  Nicolas A Giraldo; Natalia I Bolaños; Adriana Cuellar; Fanny Guzman; Ana Maria Uribe; Astrid Bedoya; Natalia Olaya; Zulma M Cucunubá; Nubia Roa; Fernando Rosas; Víctor Velasco; Concepción J Puerta; John M González
Journal:  PLoS Negl Trop Dis       Date:  2011-08-23

3.  CD8+ T-cells expressing interferon gamma or perforin play antagonistic roles in heart injury in experimental Trypanosoma cruzi-elicited cardiomyopathy.

Authors:  Jaline Coutinho Silverio; Isabela Resende Pereira; Márcio da Costa Cipitelli; Nathália Ferreira Vinagre; Maurício Martins Rodrigues; Ricardo Tostes Gazzinelli; Joseli Lannes-Vieira
Journal:  PLoS Pathog       Date:  2012-04-19       Impact factor: 6.823

4.  Inducible nitric oxide synthase in heart tissue and nitric oxide in serum of Trypanosoma cruzi-infected rhesus monkeys: association with heart injury.

Authors:  Cristiano Marcelo Espinola Carvalho; Jaline Coutinho Silverio; Andrea Alice da Silva; Isabela Resende Pereira; Janice Mery Chicarino Coelho; Constança Carvalho Britto; Otacílio Cruz Moreira; Renato Sergio Marchevsky; Sergio Salles Xavier; Ricardo Tostes Gazzinelli; Maria da Glória Bonecini-Almeida; Joseli Lannes-Vieira
Journal:  PLoS Negl Trop Dis       Date:  2012-05-08

5.  TGF-β inhibitor therapy decreases fibrosis and stimulates cardiac improvement in a pre-clinical study of chronic Chagas' heart disease.

Authors:  Roberto Rodrigues Ferreira; Rayane da Silva Abreu; Glaucia Vilar-Pereira; Wim Degrave; Marcelo Meuser-Batista; Nilma Valéria Caldeira Ferreira; Otacílio da Cruz Moreira; Natália Lins da Silva Gomes; Elen Mello de Souza; Isalira P Ramos; Sabine Bailly; Jean-Jacques Feige; Joseli Lannes-Vieira; Tania C de Araújo-Jorge; Mariana Caldas Waghabi
Journal:  PLoS Negl Trop Dis       Date:  2019-07-31

6.  Vaccination using recombinants influenza and adenoviruses encoding amastigote surface protein-2 are highly effective on protection against Trypanosoma cruzi infection.

Authors:  Rafael Polidoro Alves Barbosa; Bruno Galvão Filho; Luara Isabela Dos Santos; Policarpo Ademar Sales Junior; Pedro Elias Marques; Rafaela Vaz Sousa Pereira; Denise Carmona Cara; Oscar Bruña-Romero; Maurício Martins Rodrigues; Ricardo Tostes Gazzinelli; Alexandre Vieira Machado
Journal:  PLoS One       Date:  2013-04-24       Impact factor: 3.240

Review 7.  Role of gap junctions and hemichannels in parasitic infections.

Authors:  José Luis Vega; Mario Subiabre; Felipe Figueroa; Kurt Alex Schalper; Luis Osorio; Jorge González; Juan Carlos Sáez
Journal:  Biomed Res Int       Date:  2013-10-23       Impact factor: 3.411

8.  Trypanosoma cruzi P21: a potential novel target for chagasic cardiomyopathy therapy.

Authors:  Thaise Lara Teixeira; Fabrício Castro Machado; Aline Alves da Silva; Samuel Cota Teixeira; Bruna Cristina Borges; Marlus Alves Dos Santos; Flávia Alves Martins; Paula Cristina Brígido; Adele Aud Rodrigues; Ana Flávia Oliveira Notário; Bruno Antônio Ferreira; João Paulo Silva Servato; Simone Ramos Deconte; Daiana Silva Lopes; Veridiana Melo Rodrigues Ávila; Fernanda de Assis Araújo; Tatiana Carla Tomiosso; Marcelo José Barbosa Silva; Claudio Vieira da Silva
Journal:  Sci Rep       Date:  2015-11-17       Impact factor: 4.379

Review 9.  Regulatory Lymphoid and Myeloid Cells Determine the Cardiac Immunopathogenesis of Trypanosoma cruzi Infection.

Authors:  Manuel Fresno; Núria Gironès
Journal:  Front Microbiol       Date:  2018-03-01       Impact factor: 5.640

10.  Impact of benznidazole treatment on the functional response of Trypanosoma cruzi antigen-specific CD4+CD8+ T cells in chronic Chagas disease patients.

Authors:  Elena Pérez-Antón; Adriana Egui; M Carmen Thomas; Concepción J Puerta; John Mario González; Adriana Cuéllar; Manuel Segovia; Manuel Carlos López
Journal:  PLoS Negl Trop Dis       Date:  2018-05-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.